GCCAX | RSLCX | GCCAX / RSLCX | |
Total Expense Ratio | 0.78 | 1.30 | 60% |
Annual Report Gross Expense Ratio | 0.83 | 1.30 | 64% |
Fund Existence | 6 years | 23 years | - |
Gain YTD | 25.192 | 11.480 | 219% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 465M | 81.4B | 1% |
Annual Yield % from dividends | 0.55 | 0.39 | 141% |
Returns for 1 year | 7.46 | 12.02 | 62% |
Returns for 3 years | -15.33 | 35.73 | -43% |
Returns for 5 years | -4.05 | 15.52 | -26% |
Returns for 10 years | N/A | 55.17 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
LFSC | 28.94 | 0.41 | +1.44% |
F/m Emerald Life Sciences Innovation ETF | |||
MVFG | 29.89 | 0.25 | +0.84% |
Monarch Volume Factor Gbl Uncons ETF | |||
BWTG | 37.63 | 0.10 | +0.26% |
Brendan Wood TopGun ETF | |||
BSCP | 20.71 | N/A | +0.02% |
Invesco BulletShares 2025 Corp Bd ETF | |||
MDIV | 16.21 | -0.01 | -0.06% |
Multi-Asset Diversified Income ETF |